Reduced serum levels of adiponectin in elderly patients with major depression

Journal of Psychiatric Research

Volumn 46, Issue 8, 2012, Pages 1081-1085

  Diniz, Breno S ^a,b   Teixeira, Antonio L ^c   Campos, Alline C ^c   Miranda, Aline S ^c   Rocha, Natalia P ^c   Talib, Leda L ^a   Gattaz, Wagner F ^a   Forlenza, Orestes V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Adiponectin; Biomarker; Cognition; Elderly; Late life depression; Physiopathology

Indexed keywords

ADIPONECTIN;

AGED; ARTICLE; BODY MASS; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; LATE LIFE DEPRESSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MINI MENTAL STATE EXAMINATION; MOOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84863493735     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.04.028     Document Type: Article

References (51)

1. Adam T., Schamarek I., Springer E.A., Havel P.J., Epel E.E. Adiponectin and negative mood in healthy premenopausal and postmenopausal women. Hormones and Behavior 2010, 58:699-704.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders IV-TR 2000, Washington, DC.
3. Castro-Costa E., Dewey M., Stewart R., Banerjee S., Huppert F., Mendonca-Lima C., et al. Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study. British Journal of Psychiatry 2007, 191:393-401.
4. Cizza G., Nguyen V.T., Eskandari F., Duan Z., Wright E.C., Reynolds J.C., et al. Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study. Journal of Clinical Psychiatry 2010, 71:1079-1087.
5. Diniz B.S., Nunes P.V., Yassuda M.S., Pereira F.S., Flaks M.K., Viola L.F., et al. Mild cognitive impairment: cognitive screening or neuropsychological assessment?. Revista Brasileira de Psiquiatria 2008, 30:316-321.
6. Diniz B.S., Teixeira A.L., Talib L., Gattaz W.F., Forlenza O.V. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. American Journal of Geriatric Psychiatry 2010, 18:172-176.
7. Diniz B.S., Teixeira A.L., Talib L.L., Mendonça V.A., Gattaz W.F., Forlenza O.V. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. Journal of Psychiatric Research 2010, 44:917-920.
8. Diniz B.S., Teixeira A.L., Ojopi E.B., Talib L.L., Mendonça V.A., Gattaz W.F., et al. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. Journal of Alzheimer's Disease 2010, 22:1305-1311.
9. Fallo F., Scarda A., Sonino N., Paoletta A., Boscaro M., Pagano C., et al. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. European Journal of Endocrinology 2004, 150:339-344.
10. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J., et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2003, 301:1045-1050.
11. First M.B., Spitzer, Robert L., Gibbon Miriam, Williams, Janet B.W. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
12. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
13. Forlenza O.V., Diniz B.S., Talib L.L., Mendonca V.A., Ojopi E.B., Gattaz W.F., et al. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders 2009, 28:507-512.
14. Forlenza O.V., Diniz B.S., Talib L.L., Radanovic M., Yassuda M.S., Ojopi E.B., et al. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria 2010, 32:216-222.
15. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. Impact on 6-month survival. Journal of the American Medical Association 1993, 270:1819-1825.
16. Frasure-Smith N., Lesperance F., Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression?. Health Psychology 1995, 14:388-398.
17. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960, 23:56-62.
18. Han S.H., Quon M.J., Kim J.A., Koh K.K. Adiponectin and cardiovascular disease: response to therapeutic interventions. Journal of the American College of Cardiology 2007, 49:531-538.
19. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362.
20. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005, 29:251-255.
21. Jeong HG, Min BJ, Lim S, Kim TH, Lee JJ, Park JH, et al. Plasma adiponectin elevation in elderly individuals with subsyndromal depression. Psychoneuroendocrinology. [Epub ahead of print 2011 Nov 28].
22. Kamogawa K., Kohara K., Tabara Y., Uetani E., Nagai T., Yamamoto M., et al. Abdominal fat, adipose-derived hormones and mild cognitive impairment: the J-SHIPP study. Dementia and Geriatric Cognitive Disorder 2010, 30:432-439.
23. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 2003, 289:3095-3105.
24. Lara N., Archer S.L., Baker G.B., Le Melledo J.M. Paroxetine-induced increase in metabolic end products of nitric oxide. Journal of Clinical Psychopharmacology 2003, 23:408-412.
25. Lehto S.M., Huotari A., Niskanen L., Tolmunen T., Koivumaa-Honkanen H., Honkalampi K., et al. Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatrica Scandinavica 2010, 121:209-215.
26. Leo R., Di Lorenzo G., Tesauro M., Cola C., Fortuna E., Zanasi M., et al. Decreased plasma adiponectin concentration in major depression. Neuroscience Letters 2006, 407:211-213.
27. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 2002, 8:731-737.
28. Mast B.T., Miles T., Penninx B.W., Yaffe K., Rosano C., Satterfield S., et al. Vascular disease and future risk of depressive symptomatology in older adults: findings from the health, aging, and body composition study. Biological Psychiatry 2008, 64:320-326.
29. McIntyre R.S., Konarski J.Z., Wilkins K., Soczynska J.K., Kennedy S.H. Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being. Canadian Journal of Psychiatry 2006, 51:274-280.
30. McIntyre R.S., Park K.Y., Law C.W., Sultan F., Adams A., Lourenco M.T., et al. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. CNS Drugs 2010, 24:741-753.
31. Narita K., Murata T., Hamada T., Takahashi T., Kosaka H., Sudo S., et al. Adiponectin multimer distribution, not absolute amount of plasma, correlates with depression severity in healthy elderly subjects. Progress in Neuropsychopharmacology and Biological Psychiatry 2008, 32:124-127.
32. Narita K., Murata T., Takahashi T., Kosaka H., Omata N., Wada Y. Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Progress in Neuropsychopharmacology and Biological Psychiatry 2006, 30:1159-1162.
33. Nunes P.V., Diniz B.S., Radanovic M., Abreu I.D., Borelli D.T., Yassuda M.S., et al. CAMCOG as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. International Journal of Geriatric Psychiatry 2008, 23:1127-1133.
34. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
35. Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Archives of General Psychiatry 2006, 63:530-538.
36. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 2004, 279:12152-12162.
37. Patten S.B., Williams J.V., Esposito E., Beck C.A. Self-reported thyroid disease and mental disorder prevalence in the general population. General Hospital Psychiatry 2006, 28:503-508.
38. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 1986, 149:698-709.
39. Simon G.E., Von Korff M., Saunders K., Miglioretti D.L., Crane P.K., van Belle G., et al. Association between obesity and psychiatric disorders in the US adult population. Archives of General Psychiatry 2006, 63:824-830.
40. Taylor C.B., Youngblood M.E., Catellier D., Veith R.C., Carney R.M., Burg M.M., et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Archives General Psychiatry 2005, 62:792-798.
41. Taylor V.H., MacQueen G.M. The role of adipokines in understanding the associations between obesity and depression. Journal of Obesity 2010, 1-6. 10.1155/2010/748048.
42. Thakore J.H., Richards P.J., Reznek R.H., Martin A., Dinan T.G. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biological Psychiatry 1997, 41:1140-1142.
43. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Review of Immunology 2006, 6:772-783.
44. Une K., Takei Y.A., Tomita N., Asamura T., Ohrui T., Furukawa K., et al. Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. European Journal of Neurology 2011, 18:1006-1009.
45. Vasiliadis H.M., Lesage A., Adair C., Wang P.S., Kessler R.C. Do Canada and the United States differ in prevalence of depression and utilization of services?. Psychiatric Service 2007, 58:63-71.
46. Weber-Hamann B., Kopf D., Lederbogen F., Gilles M., Heuser I., Colla M., et al. Activity of the hypothalamus-pituitary-adrenal system and oral glucose tolerance in depressed patients. Neuroendocrinology 2005, 81:200-204.
47. Weber-Hamann B., Kratzsch J., Kopf D., Lederbogen F., Gilles M., Heuser I., et al. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment. Journal of Psychiatric Research 2007, 41:344-350.
48. Wolf A.M., Wolf D., Rumpold H., Enrich B., Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochemical and Biophysical Research Communications 2004, 323:630-635.
49. Yassuda M.S., Diniz B.S., Flaks M.K., Viola L.F., Pereira F.S., Nunes P.V., et al. Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds. Archives of Clinical Neuropsychology 2009, 24:71-79.
50. Yilmaz Y. Psychopathology in the context of obesity: the adiponectin hypothesis. Medical Hypotheses 2008, 70:902-903.
51. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.